Literature DB >> 17382831

Development of a rational scale to assess the harm of drugs of potential misuse.

David Nutt1, Leslie A King, William Saulsbury, Colin Blakemore.   

Abstract

Drug misuse and abuse are major health problems. Harmful drugs are regulated according to classification systems that purport to relate to the harms and risks of each drug. However, the methodology and processes underlying classification systems are generally neither specified nor transparent, which reduces confidence in their accuracy and undermines health education messages. We developed and explored the feasibility of the use of a nine-category matrix of harm, with an expert delphic procedure, to assess the harms of a range of illicit drugs in an evidence-based fashion. We also included five legal drugs of misuse (alcohol, khat, solvents, alkyl nitrites, and tobacco) and one that has since been classified (ketamine) for reference. The process proved practicable, and yielded roughly similar scores and rankings of drug harm when used by two separate groups of experts. The ranking of drugs produced by our assessment of harm differed from those used by current regulatory systems. Our methodology offers a systematic framework and process that could be used by national and international regulatory bodies to assess the harm of current and future drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382831     DOI: 10.1016/S0140-6736(07)60464-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  210 in total

Review 1.  Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.

Authors:  Colin N Haile; James J Mahoney; Thomas F Newton; Richard De La Garza
Journal:  Pharmacol Ther       Date:  2012-01-31       Impact factor: 12.310

2.  "I'm not afraid of those ones just 'cause they've been prescribed": perceptions of risk among illicit users of pharmaceutical opioids.

Authors:  Raminta Daniulaityte; Russel Falck; Robert G Carlson
Journal:  Int J Drug Policy       Date:  2012-03-13

3.  [Life-threatening fentanyl and propofol addiction: interview with a survivor].

Authors:  C Maier; J Leclerc-Springer
Journal:  Anaesthesist       Date:  2012-07       Impact factor: 1.041

4.  Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey.

Authors:  Benedikt Fischer; Jürgen Rehm; Hyacinth Irving; Anca Ialomiteanu; Jean-Sebastien Fallu; Jayadeep Patra
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

5.  Addiction treatment-related employment barriers: the impact of methadone maintenance.

Authors:  Lindsey Richardson; Evan Wood; Julio Montaner; Thomas Kerr
Journal:  J Subst Abuse Treat       Date:  2012-02-01

6.  Characterization of differential cocaine metabolism in mouse and rat through metabolomics-guided metabolite profiling.

Authors:  Dan Yao; Xiaolei Shi; Lei Wang; Blake A Gosnell; Chi Chen
Journal:  Drug Metab Dispos       Date:  2012-10-03       Impact factor: 3.922

Review 7.  A preliminary benefit-risk assessment of varenicline in smoking cessation.

Authors:  Kate Cahill; Lindsay Stead; Tim Lancaster
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  Cannabis controversies: how genetics can inform the study of comorbidity.

Authors:  Arpana Agrawal; Michael T Lynskey
Journal:  Addiction       Date:  2014-01-19       Impact factor: 6.526

Review 9.  Prescription stimulant medication misuse: Where are we and where do we go from here?

Authors:  Lisa L Weyandt; Danielle R Oster; Marisa E Marraccini; Bergljot Gyda Gudmundsdottir; Bailey A Munro; Emma S Rathkey; Alison McCallum
Journal:  Exp Clin Psychopharmacol       Date:  2016-10       Impact factor: 3.157

10.  Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Curr Top Behav Neurosci       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.